Firms Split Ownership 50-50
Pharmathene, Theraclone Merge Pipelines in All-Stock Transaction
By Catherine Shaffer
Thursday, August 1, 2013
A merger agreement between Pharmathene Inc., of Annapolis, Md., and Theraclone Sciences Inc., of Seattle, will create a combined company boasting four clinical-stage antibodies in the areas of infectious disease.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.